Table 2.
TAC | K1 (ml·cm−3·min−1) | Vb | VT | K1m (ml·cm−3·min−1) | VTm | ||
---|---|---|---|---|---|---|---|
R 1 | 0.34 | 0.65 | 0.05 | 4 | – | – | – |
T 1 | 0.34 | 1.3 | 0.05 | 5.59 | 0.39 | 0.50 | 0.59 |
T 2 | 0.34 | 0.8 | 0.05 | 4.37 | 0.09 | 0.50 | 0.6 |
T 3 | 0.34 | 1.0 | 0.05 | 4.86 | 0.21 | 0.50 | 0.6 |
T 4 | 0.34 | 1.2 | 0.05 | 5.34 | 0.33 | 0.50 | 0.6 |
T 5 | 0.34 | 1.4 | 0.05 | 5.83 | 0.45 | 0.50 | 0.6 |
T 6 | 0.34 | 1.6 | 0.05 | 6.31 | 0.58 | 0.50 | 0.6 |
T 7 | 0.34 | 1.8 | 0.05 | 6.80 | 0.70 | 0.50 | 0.6 |
T 8 | 0.34 | 2.1 | 0.05 | 7.53 | 0.88 | 0.50 | 0.6 |
T 9 | 0.34 | 2.3 | 0.05 | 8.01 | 1.00 | 0.50 | 0.6 |
T 10 | 0.34 | 1.3 | 0.05 | 5.59 | 0.39 | 0.00 | 0.6 |
T 11 | 0.34 | 1.3 | 0.05 | 5.59 | 0.39 | 0.01 | 0.6 |
T 12 | 0.34 | 1.3 | 0.05 | 5.59 | 0.39 | 0.03 | 0.6 |
T 13 | 0.34 | 1.3 | 0.05 | 5.59 | 0.39 | 0.05 | 0.6 |
T 14 | 0.34 | 1.3 | 0.05 | 5.59 | 0.39 | 0.50 | 0.1 |
T 15 | 0.34 | 1.3 | 0.05 | 5.59 | 0.39 | 0.50 | 0.2 |
T 16 | 0.34 | 1.3 | 0.05 | 5.59 | 0.39 | 0.50 | 0.3 |
T 17 | 0.34 | 1.3 | 0.05 | 5.59 | 0.39 | 0.50 | 0.4 |
T 18 | 0.34 | 1.3 | 0.05 | 5.59 | 0.39 | 0.50 | 0.5 |
T 19 | 0.34 | 1.3 | 0.05 | 5.59 | 0.39 | 0.50 | 0.7 |
T 20 | 0.34 | 1.3 | 0.05 | 5.59 | 0.39 | 0.50 | 0.8 |
T 21 | 0.34 | 1.3 | 0.05 | 5.59 | 0.39 | 0.50 | 0.9 |
A two-tissue reversible compartmental model with an additional single-tissue compartment for metabolites was used. K1, k2, and k3 are rate constants, Vb is fractional blood volume, and VT is volume of distribution for [18F]FDDNP. and and are binding potentials estimated directly and indirectly using the metabolite model, respectively. The indirect calculation of BPND was performed using target to reference volumes of distribution ratios. K1m is a rate constant and VTm the volume of distribution for the metabolites. During all simulations, k4 (0.099 min−1) and K1/k2 (2.4) were fixed, and same, the K1m and k2m were used in reference and target tissues